Greenyn Biotechnology Co (ROCO:6846) Interest Expense : NT$-2.1 Mil (TTM As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Greenyn Biotechnology Co Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Greenyn Biotechnology Co's interest expense for the three months ended in Mar. 2024 was NT$ -0.7 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was NT$-2.1 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Greenyn Biotechnology Co's Operating Income for the three months ended in Mar. 2024 was NT$ 46.8 Mil. Greenyn Biotechnology Co's Interest Expense for the three months ended in Mar. 2024 was NT$ -0.7 Mil. Greenyn Biotechnology Co's Interest Coverage for the quarter that ended in Mar. 2024 was 64.19. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Greenyn Biotechnology Co Interest Expense Historical Data

The historical data trend for Greenyn Biotechnology Co's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Greenyn Biotechnology Co Interest Expense Chart

Greenyn Biotechnology Co Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

-3.17

-1.75

-1.37

-1.25

-1.65

Greenyn Biotechnology Co Quarterly Data
	Dec19	Jun20	Dec20	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Interest Expense	Get a 7-Day Free Trial										-0.32	-0.47	-0.39	-0.48	-0.73

Greenyn Biotechnology Co Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$-2.1 Mil.

Greenyn Biotechnology Co (ROCO:6846) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Greenyn Biotechnology Co's Interest Expense for the three months ended in Mar. 2024 was NT$-0.7 Mil. Its Operating Income for the three months ended in Mar. 2024 was NT$46.8 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2024 was NT$53.7 Mil.

Greenyn Biotechnology Co's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Mar. 2024 )	/	Interest Expense (Q: Mar. 2024 )
	=	-1	*	46.795	/	-0.729
	=	64.19

The higher the ratio, the stronger the company's financial strength is.

Good Sign:

Ben Graham prefers companies' interest coverage to be at least 5. Greenyn Biotechnology Co Ltd has enough cash to cover all of its debt. Its financial situation is stable.

Greenyn Biotechnology Co (ROCO:6846) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Greenyn Biotechnology Co Ltd (ROCO:6846) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

5th Floor, No 43 Keya Road, Daya District, Taichung, TWN

Website

https://www.greenynbio.com

Greenyn Biotechnology Co Ltd has developed Insumate patented sequenced peptide, Antromax Antrodia cinnamomea mycelia, and Zymologist fermented liquid.

Greenyn Biotechnology Co (ROCO:6846) Headlines

No Headlines